HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mayumi Tsuji Selected Research

1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazine

1/2021Inhibition of hepatocyte growth factor/c-Met signalling abrogates joint destruction by suppressing monocyte migration in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mayumi Tsuji Research Topics

Disease

12Inflammation (Inflammations)
01/2023 - 12/2009
11Neoplasms (Cancer)
05/2024 - 11/2012
11Alzheimer Disease (Alzheimer's Disease)
12/2023 - 01/2018
6COVID-19
10/2023 - 01/2021
6Cognitive Dysfunction
07/2023 - 01/2017
5Infections
01/2024 - 02/2018
5Parkinson Disease (Parkinson's Disease)
09/2023 - 01/2019
4Asthma (Bronchial Asthma)
10/2018 - 06/2012
4Hypersensitivity (Allergy)
06/2018 - 12/2012
4Liver Diseases (Liver Disease)
06/2015 - 10/2005
3Synucleinopathies
09/2023 - 01/2019
3Premature Birth (Birth, Premature)
01/2023 - 10/2018
3Amyloid Plaque
12/2021 - 11/2018
3Dementia (Dementias)
05/2020 - 06/2015
3Glioblastoma (Glioblastoma Multiforme)
10/2015 - 11/2012
2Esophageal Neoplasms (Esophageal Cancer)
01/2024 - 05/2012
2Dermatitis
01/2023 - 09/2015
2Hypesthesia (Numbness)
01/2023 - 09/2016
2Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 10/2006
2Placenta Previa
01/2020 - 06/2019
2Fetal Growth Retardation (Intrauterine Growth Retardation)
12/2018 - 05/2014
2Heart Failure
10/2018 - 02/2018
2Edema (Dropsy)
01/2018 - 09/2017
2Hypertension (High Blood Pressure)
11/2017 - 09/2016
2Neuroblastoma
11/2016 - 02/2014
2Diabetic Retinopathy (Retinopathy, Diabetic)
09/2016 - 06/2015
2Pain (Aches)
09/2016 - 10/2015
2Triple Negative Breast Neoplasms
04/2016 - 09/2014
2Hypoglycemia (Reactive Hypoglycemia)
06/2015 - 04/2014
2Carcinogenesis
06/2013 - 01/2008
2Chronic Kidney Failure (Chronic Renal Failure)
09/2005 - 01/2005
1Carcinoma (Carcinomatosis)
05/2024
1Colonic Neoplasms (Colon Cancer)
01/2024
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023
1Hyperalgesia
01/2023
1Peripheral Nervous System Diseases (PNS Diseases)
01/2023
1Neoplasm Metastasis (Metastasis)
09/2022
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2022
1Autism Spectrum Disorder
07/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
12/2021
1Stomach Neoplasms (Stomach Cancer)
12/2021
1Disease Progression
12/2021

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
09/2023 - 11/2012
10Amyloid (Amyloid Fibrils)IBA
12/2023 - 01/2018
6Immune Checkpoint InhibitorsIBA
01/2024 - 12/2021
5Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2012
5ORALIT (ORS)IBA
01/2024 - 01/2021
5LinagliptinIBA
01/2021 - 04/2014
4SynucleinsIBA
09/2023 - 01/2019
3Environmental Pollutants (Pollutants, Environmental)IBA
01/2023 - 01/2015
3ImmunosorbentsIBA
12/2021 - 01/2019
3EnzymesIBA
12/2021 - 01/2019
3LipopolysaccharidesIBA
01/2021 - 01/2018
3Cilostazol (Pletal)FDA LinkGeneric
01/2019 - 01/2017
3Hormones (Hormone)IBA
04/2017 - 01/2008
3Messenger RNA (mRNA)IBA
01/2016 - 01/2005
2Volatile Fatty AcidsIBA
05/2024 - 01/2018
2AntibodiesIBA
09/2023 - 12/2021
2LigandsIBA
09/2023 - 01/2023
2VaccinesIBA
01/2022 - 11/2021
2Superoxide DismutaseIBA
01/2021 - 12/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2020 - 01/2019
2Immunoglobulin E (IgE)IBA
01/2020 - 12/2012
2SeleniumIBA
06/2019 - 10/2018
2ManganeseIBA
06/2019 - 10/2018
2MercuryIBA
06/2019 - 10/2018
2CadmiumIBA
06/2019 - 10/2018
2Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2018 - 01/2017
2PlasticsIBA
06/2018 - 09/2015
2Immunoglobulin G (IgG)IBA
06/2018 - 09/2015
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2018 - 06/2015
2Insulin (Novolin)FDA Link
09/2016 - 06/2015
2NAD (NADH)IBA
09/2016 - 12/2009
2Polychlorinated Biphenyls (PCBs)IBA
05/2015 - 06/2012
2Air Pollutants (Pollutants, Air)IBA
05/2015 - 01/2015
2C-Reactive ProteinIBA
04/2014 - 05/2009
2Bile Acids and Salts (Bile Acids)IBA
11/2007 - 10/2006
1isobutyric acidIBA
05/2024
1NivolumabIBA
09/2023
1pembrolizumabIBA
09/2023
1Raloxifene Hydrochloride (Evista)FDA Link
07/2023
1Galectin 3 (LGALS3)IBA
01/2023
1A-factor (Streptomyces)IBA
01/2023
1B7-H1 AntigenIBA
01/2023
1Ointments (Pastes)IBA
01/2023
1bisphenol F diglycidyl etherIBA
01/2023
1Semaphorin-3AIBA
09/2022
1Oxidopamine (6 Hydroxydopamine)IBA
09/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
07/2022
1Valproic Acid (Depakote)FDA LinkGeneric
07/2022

Therapy/Procedure

7Therapeutics
05/2024 - 06/2013
4Drug Therapy (Chemotherapy)
01/2024 - 06/2013
3Immunotherapy
05/2024 - 01/2023
2Aftercare (After-Treatment)
01/2024 - 04/2014
2Renal Dialysis (Hemodialysis)
04/2014 - 09/2005
1Oral Administration
05/2024
1Bathroom Equipment
01/2023
1Fecal Microbiota Transplantation
01/2023
1Massage (Zone Therapy)
01/2023
1Chemical Sympathectomy
09/2022